|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
1.660 -0.020 (-1.190%) | 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 441,153 | -25.398% | 591,339 | 796,976 | 616,693 | 587,427 |
| Cost of Sales | (370,790) | -25.117% | (495,157) | (663,376) | (526,818) | (520,823) |
| Gross Profit | 70,363 | -26.844% | 96,182 | 133,600 | 89,875 | 66,604 |
| 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | (10,433) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 339 | -48.792% | 662 | (6,727) | (499) | 5,180 | |
| Profit / (Loss) before Taxation | (5,887) | -73.837% | (22,501) | (44,300) | (125,753) | (254,678) | |
| Taxation | (1,793) | -- | 1,617 | 0 | 0 | (2,819) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (332) | 637.778% | (45) | 69 | 241 | 280 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (8,012) | -61.718% | (20,929) | (44,231) | (125,512) | (257,217) | |
| 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,707) | -- | 2,166 | (4,226) | 1,400 | 10,692 |
| Depreciation & Amortisation | 6,874 | -3.278% | 7,107 | 8,907 | 20,474 | 58,196 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -10.000 | -68.153% | -31.400 | -79.500 | -310.400 | -665.800 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.243467 | -- | 4.82105 | 6.464274 | 10.078452 | 25.689321 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -26,006 |
| %Change | -- |
| EPS / (LPS) | RMB -0.325 |
| NBV Per Share (¥) | RMB 3.964 |